Biogen Inc. shares fell 2.3% in pre-conference trading, as the company announced quarterly earnings and earnings that were lower than analysts’ estimates. Biogen posted a net profit of $ 303.8 million, or $ 2.06 per share, in the first quarter, down from $ 410.2 million, or $ 2.69, a year earlier. Adjusted earnings per share […]
Menu